Schaumburg Federico, Pujato Nazarena, Peverengo Luz María, Marcipar Iván Sergio, Berli Claudio Luis Alberto
INTEC (Universidad Nacional del Litoral-CONICET), Predio CCT CONICET-Santa Fe, RN 168, Santa Fe, S3000GLN, Argentina.
Laboratorio de Tecnología Inmunológica (FBCB, Universidad Nacional del Litoral), Ciudad Universitaria, RN 168, Santa Fe, S3000GLN, Argentina.
Talanta. 2023 May 1;256:124246. doi: 10.1016/j.talanta.2022.124246. Epub 2023 Jan 5.
Chagas disease (CD) affects about 7 million people worldwide, presents a large prevalence in Latin America, and is growing in the rest of the world, where congenital CD is the main mode of transmission. Point-of-care testing (POCT) methods are increasingly required to ease early diagnostics and increase treatment success. This work presents the development and validation of a smartphone-integrated ELISA-based POCT system for the detection of both chronic and congenital CD. Expensive and bulky equipment used for ELISA in conventional laboratories was replaced as follows. A miniaturized device was fabricated for incubation of commercial ELISA plates, achieving ∼±1 °C uniformity and stability. The ELISA plate reader was replaced by smartphone camera and image processing, comprising algorithms to account for variability sources and spatial light non-uniformity; thus, additional hardware like a dark-box is not required. The agreement between samples classified with this novel reading method vs. ELISA plate reader was found to be 99.7% and 95.4% for chronic and congenital CD, respectively. Furthermore, a smartphone application was designed and implemented to guide the user during the assay, provide connectivity, and access databases, facilitating patient monitoring and health-policy making. The whole system is aimed to be used as a practical diagnostic tool in primary health care settings, as well as to facilitate patients' follow-up to provide better treatment. Concerning the technology itself, the proposed POCT platform is versatile enough to be readily adapted for the detection of other infectious diseases.
恰加斯病(CD)在全球约影响700万人,在拉丁美洲患病率很高,且在世界其他地区呈增长态势,在这些地区先天性恰加斯病是主要传播方式。即时检测(POCT)方法对于简化早期诊断和提高治疗成功率的需求日益增加。这项工作展示了一种基于酶联免疫吸附测定(ELISA)的与智能手机集成的POCT系统的开发与验证,用于检测慢性和先天性恰加斯病。传统实验室中用于ELISA的昂贵且笨重的设备被如下替换。制造了一种小型化设备用于商业ELISA板的孵育,实现了约±1°C的均匀性和稳定性。ELISA酶标仪被智能手机摄像头和图像处理所取代,其中包括考虑变异性来源和空间光不均匀性的算法;因此,不需要像暗箱这样的额外硬件。用这种新颖的读取方法分类的样本与ELISA酶标仪之间的一致性,对于慢性和先天性恰加斯病分别为99.7%和95.4%。此外,设计并实现了一个智能手机应用程序,以在检测过程中指导用户、提供连接并访问数据库,便于患者监测和卫生政策制定。整个系统旨在用作初级卫生保健机构中的实用诊断工具,并促进患者随访以提供更好的治疗。就技术本身而言,所提出的POCT平台具有足够的通用性,能够很容易地适用于其他传染病的检测。